Literature DB >> 20703463

Clinical implication of the number of central lymph node metastasis in papillary thyroid carcinoma: preliminary report.

Yoon Se Lee1, Yun Sung Lim, Jin-Choon Lee, Soo-Geun Wang, In-Ju Kim, Byung-Joo Lee.   

Abstract

BACKGROUND: Papillary thyroid cancer (PTC) metastasizes to central lymph node (CLN). CLN metastasis is associated with high risk of locoregional recurrence and distant metastasis. The significance of the number of metastatic CLN has not been addressed. This study was designed to evaluate the clinical implication of the number of metastatic CLN in PTC.
METHODS: We reviewed the patients who underwent total thyroidectomy and CLN dissection with or without lateral neck dissection due to PTC, from March 2008 to June 2009. The relationships between the number of CLN and risk factors, including age, gender, tumor size, extrathyroidal extension, and lateral lymph node metastasis, were assessed. Patients were divided into three groups according to the number of CLN: group A = 0; group B = 1-2; and group C = ≥3.
RESULTS: Of 258 patients enrolled in this study, 113 were in group A, 73 in group B, and 72 in group C. Extrathyroidal extension and lateral neck lymph node metastasis were related to increased rate of CLN metastasis (P < 0.05). Tumor size increased as the number of CLN increased; group C had the largest tumor size (P < 0.05). When evaluating the distribution of patients with extrathyroidal extension, group C had a significant odds ratio (4.213, P < 0.05). When evaluating the distribution of lateral neck lymph node metastasis, groups B and C had significant odds ratio (14.353, 75.403, respectively, P < 0.05).
CONCLUSIONS: The number of CLN metastasis correlated with the negative prognostic factors, including tumor size, extrathyroidal extension, and lateral neck lymph node metastasis. This suggests that the number of CLN has prognostic implication.

Entities:  

Mesh:

Year:  2010        PMID: 20703463     DOI: 10.1007/s00268-010-0749-0

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  39 in total

1.  Risk factors for recurrence to the lymph node in papillary thyroid carcinoma patients without preoperatively detectable lateral node metastasis: validity of prophylactic modified radical neck dissection.

Authors:  Yasuhiro Ito; Takuya Higashiyama; Yuuki Takamura; Akihiro Miya; Kaoru Kobayashi; Fumio Matsuzuka; Kanji Kuma; Akira Miyauchi
Journal:  World J Surg       Date:  2007-11       Impact factor: 3.352

2.  Predictive factors for ipsilateral or contralateral central lymph node metastasis in unilateral papillary thyroid carcinoma.

Authors:  Bon Seok Koo; Eun Chang Choi; Yeo-Hoon Yoon; Dong-Hyun Kim; Eung-Hyub Kim; Young Chang Lim
Journal:  Ann Surg       Date:  2009-05       Impact factor: 12.969

3.  A vision for the surgical management of papillary thyroid carcinoma: extensive lymph node compartmental dissections and selective use of radioiodine.

Authors:  Ernest L Mazzaferri
Journal:  J Clin Endocrinol Metab       Date:  2009-04       Impact factor: 5.958

4.  Clinically significant prognostic factors for differentiated thyroid carcinoma: a population-based, nested case-control study.

Authors:  Catharina Ihre Lundgren; Per Hall; Paul W Dickman; Jan Zedenius
Journal:  Cancer       Date:  2006-02-01       Impact factor: 6.860

5.  Prognostic variables of papillary thyroid carcinomas with local invasion.

Authors:  J D Lin; T C Chao; H F Weng; Y S Ho
Journal:  Endocr J       Date:  1999-02       Impact factor: 2.349

6.  Prognostic factors in well-differentiated thyroid carcinoma.

Authors:  Sharon L Cushing; Carsten E Palme; Nathalie Audet; Spiro Eski; Paul G Walfish; Jeremy L Freeman
Journal:  Laryngoscope       Date:  2004-12       Impact factor: 3.325

7.  Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer.

Authors:  E L Mazzaferri; S M Jhiang
Journal:  Am J Med       Date:  1994-11       Impact factor: 4.965

Review 8.  Level VI lymph node dissection for papillary thyroid cancer.

Authors:  M L White; G M Doherty
Journal:  Minerva Chir       Date:  2007-10       Impact factor: 1.000

9.  Risk factors contributing to a poor prognosis of papillary thyroid carcinoma: validity of UICC/AJCC TNM classification and stage grouping.

Authors:  Yasuhiro Ito; Akira Miyauchi; Tomoo Jikuzono; Takuya Higashiyama; Yuuki Takamura; Akihiro Miya; Kaoru Kobayashi; Fumio Matsuzuka; Kiyoshi Ichihara; Kanji Kuma
Journal:  World J Surg       Date:  2007-04       Impact factor: 3.352

10.  Prognostic parameters for recurrence of papillary thyroid microcarcinoma.

Authors:  Tae Yong Kim; Suck Joon Hong; Jung Min Kim; Won Gu Kim; Gyungyub Gong; Jin Sook Ryu; Won Bae Kim; Sung-Cheol Yun; Young Kee Shong
Journal:  BMC Cancer       Date:  2008-10-14       Impact factor: 4.430

View more
  21 in total

1.  Prediction of central lymph node metastasis in 392 patients with cervical lymph node-negative papillary thyroid carcinoma in Eastern China.

Authors:  Yingying Xiang; Kuailu Lin; Siyang Dong; L I Qiao; Qiuxiang He; Xiaohua Zhang
Journal:  Oncol Lett       Date:  2015-07-29       Impact factor: 2.967

Review 2.  Impact of prophylactic central neck dissection on oncologic outcomes of papillary thyroid carcinoma: a review.

Authors:  Elisabeth Mamelle; Isabelle Borget; Sophie Leboulleux; Haïtham Mirghani; Carlos Suárez; Phillip K Pellitteri; Ashok R Shaha; Marc Hamoir; K Thomas Robbins; Avi Khafif; Juan P Rodrigo; Carl E Silver; Alessandra Rinaldo; Alfio Ferlito; Dana M Hartl
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-06-11       Impact factor: 2.503

3.  Intraoperative frozen section for the evaluation of extrathyroidal extension in papillary thyroid cancer.

Authors:  Young Min Park; Soo-Geun Wang; Jin Young Goh; Dong Hoon Shin; In-Ju Kim; Byung-Joo Lee
Journal:  World J Surg       Date:  2015-01       Impact factor: 3.352

4.  The number of positive lymph nodes in the central compartment has prognostic impact in papillary thyroid cancer.

Authors:  Parameswaran Rajeev; Sohail Ahmed; Tarek M Ezzat; Gregory P Sadler; Radu Mihai
Journal:  Langenbecks Arch Surg       Date:  2012-12-30       Impact factor: 3.445

5.  Downregulation of uPAR inhibits migration, invasion, proliferation, FAK/PI3K/Akt signaling and induces senescence in papillary thyroid carcinoma cells.

Authors:  Theodore S Nowicki; Hong Zhao; Zbigniew Darzynkiewicz; Augustine Moscatello; Edward Shin; Stimson Schantz; Raj K Tiwari; Jan Geliebter
Journal:  Cell Cycle       Date:  2011-01-01       Impact factor: 4.534

6.  Expression of signal transducer and activator of transcription 3 and its phosphorylated form is significantly upregulated in patients with papillary thyroid cancer.

Authors:  L I Yan; L I Li; Qinghuai Li; Wang DI; Wei Shen; Linlei Zhang; Hao Guo
Journal:  Exp Ther Med       Date:  2015-04-07       Impact factor: 2.447

Review 7.  German Association of Endocrine Surgeons practice guideline for the surgical management of malignant thyroid tumors.

Authors:  Henning Dralle; Thomas J Musholt; Jochen Schabram; Thomas Steinmüller; Andreja Frilling; Dietmar Simon; Peter E Goretzki; Bruno Niederle; Christian Scheuba; Thomas Clerici; Michael Hermann; Jochen Kußmann; Kerstin Lorenz; Christoph Nies; Peter Schabram; Arnold Trupka; Andreas Zielke; Wolfram Karges; Markus Luster; Kurt W Schmid; Dirk Vordermark; Hans-Joachim Schmoll; Reinhard Mühlenberg; Otmar Schober; Harald Rimmele; Andreas Machens
Journal:  Langenbecks Arch Surg       Date:  2013-03-03       Impact factor: 3.445

8.  Adequacy of pathology reports of specimens from patients with differentiated thyroid cancer.

Authors:  Ma Luisa Isidro; Gloria Lugo; Olga Fidalgo; Sara García-Arias
Journal:  Endocr Pathol       Date:  2012-12       Impact factor: 3.943

9.  Bilaterality weighs more than unilateral multifocality in predicting prognosis in papillary thyroid cancer.

Authors:  Ning Qu; Ling Zhang; Wei-Li Wu; Qing-Hai Ji; Zhong-Wu Lu; Yong-Xue Zhu; Dao-Zhe Lin
Journal:  Tumour Biol       Date:  2016-01-07

10.  Value of sentinel lymph node biopsy in papillary thyroid cancer: initial results of a prospective trial.

Authors:  R N Cabrera; C T Chone; D Zantut-Wittmann; P Matos; D M Ferreira; P S G Pereira; R J R Ferrari; A O Santos; A N Crespo; E C S C Etchebehere
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-04-03       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.